HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The ErbB3-binding protein Ebp1 suppresses androgen receptor-mediated gene transcription and tumorigenesis of prostate cancer cells.

Abstract
Down-regulation of the androgen receptor (AR) is being evaluated as an effective therapy for the advanced stages of prostate cancer. We report that Ebp1, a protein identified by its interactions with the ErbB3 receptor, down-regulates expression of AR and AR-regulated genes in the LNCaP prostate cancer cell line. Using microarray analysis, we identified six endogenous AR target genes, including the AR itself, that are down-regulated by ebp1 overexpression. Chromatin immunoprecipitation assays revealed that Ebp1 was recruited to the prostate-specific antigen gene promoter in response to the androgen antagonist bicalutamide, suggesting that Ebp1 directly affected the expression of AR-regulated genes in response to androgen antagonists. Ebp1 expression was reduced in cells that had become androgen-independent. Androgens failed to stimulate either the growth of ebp1 transfectants or transcription of AR-regulated reporter genes in these cells. The agonist activity of the antiandrogen cyproterone acetate was abolished in ebp1 transfectants. In severe combined immunodeficient mice, Ebp1 overexpression resulted in a reduced incidence of LNCaP tumors and slower tumor growth. These findings suggest that Ebp1 is a previously unrecognized therapeutic target for treatment of hormone refractory prostate cancer.
AuthorsYuexing Zhang, Xin-Wei Wang, Danijela Jelovac, Takeo Nakanishi, Myoung-Hee Yu, Damilola Akinmade, Olga Goloubeva, Douglas D Ross, Angela Brodie, Anne W Hamburger
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 102 Issue 28 Pg. 9890-5 (Jul 12 2005) ISSN: 0027-8424 [Print] United States
PMID15994225 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Adaptor Proteins, Signal Transducing
  • Androgen Antagonists
  • Anilides
  • Carrier Proteins
  • DNA Primers
  • Nitriles
  • PA2G4 protein, human
  • RNA-Binding Proteins
  • Receptors, Androgen
  • Tosyl Compounds
  • Cyproterone Acetate
  • bicalutamide
  • Luciferases
  • Receptor, ErbB-3
Topics
  • Adaptor Proteins, Signal Transducing
  • Androgen Antagonists (metabolism)
  • Anilides (metabolism)
  • Animals
  • Blotting, Western
  • Carrier Proteins (metabolism)
  • Cell Line, Tumor
  • Chromatin Immunoprecipitation
  • Cyproterone Acetate (metabolism)
  • DNA Primers
  • Enzyme-Linked Immunosorbent Assay
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Luciferases
  • Male
  • Mice
  • Mice, SCID
  • Nitriles
  • Oligonucleotide Array Sequence Analysis
  • Prostatic Neoplasms (metabolism, therapy)
  • RNA-Binding Proteins
  • Receptor, ErbB-3 (metabolism)
  • Receptors, Androgen (metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Tosyl Compounds

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: